HLS Therapeutics Affirms FY2026 Sales Guidance of $56.000M-$60.000M vs $58.338M Est

Benzinga · 2d ago
HLS Therapeutics (TSX:HLS) affirms FY2026 sales outlook from $56.000 million-$60.000 million to $56.000 million-$60.000 million vs $58.338 million estimate.